This stuff with Amarex and "sequences" is troublin
Post# of 148174
I understand NP & team hating Amarex - I do. But it makes no sense that cash or a contract dispute would cause CytoDyn to delay receiving critical data - the delay no doubt costs many times any disputed amount. I'm not even sure if it relates to data Amarex has or to data NP thinks Amarex can get.
And, per the great minds on this board, can we get in one place WTF ARE THESE SEQUENCES? The only thing I'm confident saying is that they relate to the HIV BLA and likely receptor occupancy, but conceivably tropism. What does it take to recreate them independently?
Friends over time on this board - please help me by clearing this up.
Citations to the time discussed on the YouTube of Emerging Growth (which this post replies to) are welcome. Thanks.